Xeris Biopharma Holdings, Inc. (XERS)
8.58
+0.15
(+1.78%)
USD |
NASDAQ |
Sep 02, 16:00
8.53
-0.05
(-0.58%)
After-Hours: 20:00
Xeris Biopharma Holdings Total Return Level : 8.58 for Sept. 2, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 02, 2026 | 8.58 |
| September 01, 2026 | 8.43 |
| August 31, 2026 | 8.44 |
| August 28, 2026 | 8.48 |
| August 27, 2026 | 8.60 |
| August 26, 2026 | 8.68 |
| August 25, 2026 | 8.74 |
| August 24, 2026 | 8.74 |
| August 21, 2026 | 8.70 |
| August 20, 2026 | 8.60 |
| August 19, 2026 | 8.78 |
| August 18, 2026 | 8.85 |
| August 17, 2026 | 8.52 |
| August 14, 2026 | 8.60 |
| August 13, 2026 | 8.33 |
| August 12, 2026 | 8.49 |
| August 11, 2026 | 8.39 |
| August 10, 2026 | 7.99 |
| August 07, 2026 | 7.93 |
| August 06, 2026 | 7.36 |
| August 05, 2026 | 8.11 |
| August 04, 2026 | 8.19 |
| August 03, 2026 | 8.13 |
| July 31, 2026 | 8.08 |
| July 30, 2026 | 8.42 |
| Date | Value |
|---|---|
| July 29, 2026 | 8.38 |
| July 28, 2026 | 8.24 |
| July 27, 2026 | 8.21 |
| July 24, 2026 | 8.32 |
| July 23, 2026 | 8.41 |
| July 22, 2026 | 8.38 |
| July 21, 2026 | 8.78 |
| July 20, 2026 | 8.60 |
| July 17, 2026 | 8.80 |
| July 16, 2026 | 8.69 |
| July 15, 2026 | 8.70 |
| July 14, 2026 | 8.28 |
| July 13, 2026 | 8.16 |
| July 10, 2026 | 8.34 |
| July 09, 2026 | 8.62 |
| July 08, 2026 | 8.67 |
| July 07, 2026 | 8.94 |
| July 06, 2026 | 8.37 |
| July 02, 2026 | 8.28 |
| July 01, 2026 | 8.00 |
| June 30, 2026 | 7.92 |
| June 29, 2026 | 7.74 |
| June 26, 2026 | 7.69 |
| June 25, 2026 | 7.40 |
| June 24, 2026 | 7.40 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Zevra Therapeutics, Inc. | 12.30 |
| Aclaris Therapeutics, Inc. | 6.18 |
| ANI Pharmaceuticals, Inc. | 73.06 |
| Corcept Therapeutics, Inc. | 110.43 |
| Veru, Inc. | 3.215 |